학술논문
Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management
Document Type
Article
Author
Source
In ESMO Open February 2022 7(1)
Subject
Language
ISSN
2059-7029